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Abstract
Background: Viruses can fall prey to their defective interfering (DI) particles. When viruses are cultured by serial
passage on susceptible host cells, the presence of virus-like DI particles can cause virus populations to rise and fall,
reflecting predator-prey interactions between DI and virus particles. The levels of virus and DI particles in each
population passage can be determined experimentally by plaque and yield-reduction assays, respectively.
Results: To better understand DI and virus particle interactions we measured vesicular stomatitis virus and DI
particle production during serial-passage culture on BHK cells. When the multiplicity of infection (MOI, or ratio of
infectious virus particles to cells) was fixed, virus yields followed a pattern of progressive decline, with higher MOI
driving earlier and faster drops in virus level. These patterns of virus decline were consistent with predictions from
a mathematical model based on single-passage behavior of cells co-infected with virus and DI particles. By
contrast, the production of virus during fixed-volume passages exhibited irregular fluctuations that could not be
described by either the steady-state or regular oscillatory dynamics of the model. However, these irregularities
were, to a significant degree, reproduced when measured host-cell levels were incorporated into the model,
revealing a high sensitivity of virus and DI particle populations to fluctuations in available cell resources.
Conclusions: This study shows how the development of mathematical models, when guided by quantitative
experiments, can provide new insight into the dynamic behavior of virus populations.
Background
Defective interfering (DI) particles are virus-like bypro-
ducts of infections that are unable to infect cells on
their own because they carry mutations, typically large
deletions, in essential viral genes. However, when DI
particles and standard virus particles co-infect the same
cell the DI particles compete for resources that ulti-
mately enable them to reproduce at the expense of virus
particles. DI particles were discovered more than 60
years ago [1,2], and their generation by diverse DNA
and RNA viruses has been widely documented [3-5], but
it is not yet known what role DI particles may play in
the behavior of natural infections. Defective viral gen-
omes have been isolated from natural infections [5-8],
but their potential for interference and their broader
roles in viral pathogenesis remain open.
The unique biological properties of DI particles make
them interesting and important for several reasons.
First, their ability to interfere with standard virus infec-
tions highlights their potential use as therapeutic agents
[9]. Moreover, the use of site-specific mutagenesis or
reverse genetics to precisely create desired genomic
defects, or introduce new functions, opens applications
for DI particles as vaccines or prophylactics [10,11]. Sec-
ond, their ability to activate innate immunity can alter
the susceptibility of host cells to infection by standard
virus [12,13]. Here, advances in the understanding of DI
particle interactions with cells may suggest new ways to
modulate how viruses grow and spread within a host.
Third, mixtures of different DI particles can comple-
ment their own defects and thereby productively infect
cells in the absence of standard virus [14-16]. This
example provides an intriguing mechanism for viral
infections to spread and persist in the absence of a sin-
gle agent that can be isolated and cultured. Such mix-
tures may also offer advantages as a vaccines [17].
Finally, the ability of DI particles to adapt their degree
of interference in response to mutation and selection of * Correspondence: yin@engr.wisc.edu
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design of anti-viral strategies that resist escape [19,20].
A characteristic feature of DI particles is their emer-
gence and outgrowth during high multiplicities of infec-
tion (MOI), where numerous copies of the standard
virus infect each host cell. Under such conditions “pre-
dator” DI particles can productively interact with “prey”
cells infected with standard virus. Ecological models of
predator-prey behavior have been proposed to describe
the dynamics of virus and DI particle populations
[21-26], where the models have been loosely based on
diverse measures of virus and DI particles, reviewed
elsewhere [27]. However, the development of population
dynamic models of virus and their DI particles have yet
to be fully integrated with quantitative experiments.
Recently, we used a yield-reduction assay to quantify
how DI particles of vesicular stomatitis virus (VSV)
impact the production of virus and DI particles in BHK
cells, where we interpreted these measures using a
mathematical model. The model enabled us to estimate
parameters that describe how input levels of virus, DI
particles and host cells interact to define outputs, speci-
fically the production of virus and DI particles in a sin-
gle passage [28]. Here we extend this data-driven
modeling approach to better understand how virus and
DI particle interactions impact their population behavior
over multiple passages.
Methods
Cell and virus culture
The maintenance and analysis of host cell and virus cul-
tures followed established methods [28]. Briefly, BHK-21
cells were cultured at 37°C and 5% CO2 in Eagle’s Mini-
mum Essential media (MEM, Cell Gro) with 5% Gluta-
maxTM (Gibco) with 10% fetal bovine serum (FBS,
Hyclone); the media was switched 2% FBS for all virus
infections. All studies employed VSV-N1, a molecularly
well-defined virus strain based on the San Juan isolate
of the Indiana serotype of VSV [29], generously pro-
vided by Gail Wertz. Virus stock was prepared by per-
forming six plaque-to-plaque transfers, using 0.2 ml
plaque-purified virus (10
4 PFU/ml) to inoculate 8 × 10
6
cells in a T-75 flask (BD Falcon), incubating 24 h at
37°C, passing through a 0.22 micron filter (Nalgene),
and storing at -80°C. The stock titer was 1 × 10
9 PFU
per ml, and the absence of detectable DI particle activity
was confirmed by the yield-reduction assay.
Yield-reduction assay for interference
T h ei n t e r f e r e n c eo fV S Vi n f e c t i o nb yD Ip a r t i c l e sw a s
quantified by the yield-reduction assay [28,30]. Prior to
all infections cells from cultures prepared in parallel
were counted, enabling control of the multiplicity of
infection (MOI), and quantification of virus yields and
interference units on a per-cell basis. Cells were then
infected with a range of serial dilutions, 1-to-10 or 1-to-
2 of each sample, incubated 1 h at 37°C for adsorption,
supplemented with stock virus to MOI 20, and incu-
bated 1 h; then each culture well was rinsed twice with
Hank’s balanced salt solution (HBSS, Hyclone), replaced
with MEM containing 2% FBS, incubated 24 h at 37°C
to produce virus and DI particle progeny, and stored at
-80°C until quantification by plaque assay.
Serial-passage culture
Prior to each virus passage, fresh cells from parallel-pre-
pared cultures were counted. Typical passage infections
used 1.6 × 10
6 cells per well in a six-well plate. For
fixed-MOI cultures the virus level from each passage
was determined by plaque assay and diluted using cell
culture media with 2% FBS to set the MOI for the next
passage. To infect, 100 microliters of the diluted virus
solution was added to the cell monolayer. The dish was
then swirled so that the virus solution would fully coat
the cell monolayer. After incubation at 37°C for 1 h, the
virus solution was removed, and 2 ml of cell culture
media with 2% FBS was pipetted into the well. The
wells were then incubated at 37°C for 23 h. After this
incubation period the solution was mixed by pipetting,
aliquoted, and stored at -90°C until diluted for titering
or use in a subsequent infection. For fixed-volume pas-
sages, cell culture media containing 2% FBS was added
to the well immediately upon removal of the media con-
taining 10% FBS. Each passage infection was initiated by
transferring 20 microliters of the mixed virus solution
from the previous passage. The infection was then incu-
bated at 37°C for 24 hours and harvested, as described
above.
Model construction
As detailed in the Results section, difference equations
linking inputs and outputs of infection were employed
to estimate overall yields of virus and DI particles. Para-
meter values (p) were estimated by least squares:
min [log ( ) log ]
p
observed predicted 10 10
2
− () ∑
with the summation spanning the available data
points. The corresponding confidence intervals were
constructed by parametric bootstrapping percentile
method using multiple resamples from the fitted model
as detailed elsewhere [31].
Results
Fixed-volume versus fixed-MOI passaging
Over the course of 13 fixed-volume passages levels of
virus production from cell monolayers dropped more
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Page 2 of 10than 10-fold, and passage-to-passage titers of virus fluc-
tuated up to 100-fold (Fig. 1a), producing drops and
recoveries in virus yield that are indicative of infections
containing mixtures of virus and its defective interfering
particles [5,32]. These changes in virus yield during
fixed-volume passaging also impacted the passage-to-
passage MOI, which varied from above 10 to below 0.1
(Fig. 1a). When passages were performed with fixed
MOI, rather than fixed volume, more regular and rapid
declines in virus productivity occurred at higher MOI
passages (Fig. 1b), providing evidence that DI particles
accumulate in populations more rapidly during passage
at high MOI. For passages at MOI 100 and 50, the aver-
age virus yield dropped 10-to-100 fold by passage three,
a loss that required nine passages at MOI 1.
To better understand how the accumulation of DI
particles across fixed-MOI passages impacts virus yields
we quantified the activity of interfering particles in dif-
ferent passage populations using the yield-reduction
assay (Fig. 2). At high MOI (100 and 50) a large drop in
virus levels between passages 2 and 3 was accompanied
by a significant DI particle activity by passage 2. In both
cases DI particle activity surpassed virus activity by pas-
sage 3. Passaging at MOI 10 brought about a more gra-
dual decline of virus activity than passaging at higher
MOIs, and DI particle levels did not surpass levels of
infectious virus. For the lowest MOIs (5 and 1), emer-
ging DI particles fluctuated in their activities, and more
passages were required to cause the largest drops in
virus yield. In most cases DI particle production in pas-
sage 1 was below the detection limit (see the exception
for MOI 50), so data points were not shown.
Model of virus and DI particle population dynamics
To quantitatively assess the effects of virus-DI particle
interactions during serial-passage culture we applied a
mathematical model that we recently developed to
quantitatively account for the input-output behavior of
single passages [28]. Briefly, the model accounts for cells
(C), virus particles (V), and interference equivalents (IE).
Figure 1 Virus production during passage cultures. (a) Virus production during fixed-volume passages (upper panel), with corresponding cell
number (middle panel) and multiplicity of infection (MOI, lower panel); (b) Virus production during fixed-MOI passages for MOI of 100 (filled
circles), 50 (open circles), 10 (filled triangles), 5 (open triangles), 1 (filled diamonds), and 0.1 (open diamonds); cultures were stopped when virus
yields fell below levels needed to maintain the MOI.
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Page 3 of 10An IE is defined experimentally as the quantity of DI
particles that fully inhibit production of viable virus par-
ticles when delivered to an infected cell. Historically, it
was assumed that the presence of single DI particle dur-
ing co-infection with virus could fully inhibit production
of viable virus particles [30]. However, our recent study
suggests this classical assumption has limitations [28]. In
our model we assume that each DI particle contributes
an equivalent share of the total interference, a quantity
we define as one interference unit (IU). It follows that
multiple IUs may be need to achieve the effect of one
IE; in our model the parameter z is the number of IUs
per IE. The model equations are:
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where the output concentration of virus particles from
the N
th passage (VN+1) depends on virus amplification
in cells initially infected with either virus alone (CV)o r
cells co-infected with both virus and IEs (CB). The out-
put concentration of IEs from the N
th passage (IEN+1)
depends on their average production from co-infected
cells (CB) and their generation from IE-free infected
cells (CV). To determine how the initial number of cells
(CN) distribute among those that contain virus alone
Figure 2 Productivity of virus and DI particles during fixed -MOI passage. Passages were carried out at MOI 100, 50, 10, 5 and 1. Closed
symbols are virus yield (PFU/cell) and open symbols are DI particle yields (DIP/cell).
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Page 4 of 10(CV)o rv i r u sa n dI E s( C B) we assume that particles
encounter and infect cells following a Poisson distribu-
tion, as shown in equations 3 and 4. The model has
nine parameters, presented in Table 1. In addition to z,
three parameters describe the productivity of virus, and
five parameters describe the productivity of IEs. In the
absence of DI particles a virus-infected cell produces an
average of b virus particles. This productivity level is
then modified by parameters p and q which describe
how the virus productivity changes depending on the
dose of interference. The negative sign on p reflects the
reduction in virus yield from DI particle co-infection,
and the positive value of q accounts for a partial
recovery of virus yield for large co-infecting doses of DI
particles. The IEs are either generated de novo from
virus-infected cells (CV), described by the parameter g,
or amplified from co-infected cells (CB), described by
the parameter d. The effects of IE co-infection on IE
yield is then modified by the parameters r, s,a n dw.A t
low levels IEs enhance their own production, reflected by
the positive value of r.A th i g h e rI E ,w h e r e(IEN·z/CN) is
greater than w, then IEs inhibit their own production,
reflected by the negative value on s. The notation ( )+ indi-
cates that only the positive part of the difference is used,
so the s-term only contributes to IE when (IEN·z/CN)
exceeds w. These parameters were estimated from the sin-
gle-passage productivity of both virus and IEs, quantified
from cells co-infected by serial dilutions an IE-rich inocu-
lum and excess virus [28].
For fixed-MOI passages the model captured several
essential features of the data (Fig. 3a): a more than 100-
fold drop in virus production between passages 2 and 3
at MOI 100, trailed by a two-passage lag for drops in
virus production at MOI 10, and a further lag for MOI 5.
At MOI 5 the model matched the overall trend of the
observed decline in virus production but it overesti-
mated virus productivities at each passage by 4- to
150-fold. Predictions for MOI 1 showed the greatest
deviations, with observed titers dropping 150-fold over
9 passages while predicted trajectories stayed level. For
fixed-volume passages the model captured overall
observed declines in virus productivity as well as major
fluctuations between passages 6 and 9, as shown in Fig.
3b. Greater deviation between the model and the data
appeared for later passages, where the model predicted
greater recovery of virus prod u c t i o nt h a no b s e r v e df o r
passages 10 to 14.
Sensitivity of simulated fixed-volume passages to inputs
Our model for fixed-volume passages depends on the
volume of sample transferred at each passage, the num-
ber of cells infected, and levels of virus and IEs in the
initial culture. Differences in initial levels of virus had
negligible effects on overall yields, so we used our
model to test how variation in other the transfer volume
and cell number affected the simulated or predicted
population behavior.
When transfer volumes were increased from 1 to 100
microliters simulated virus production levels dropped
and IE activities rose rapidly (Fig. 4a/4b), reflecting the
dominating effects of transferring more IEs from one
passage to the next. For transfer volumes of 20 microli-
ters or less, a steady-state arose from a balance between
effects of IE depletion by dilution and IE replenishment
by generation and replication.
Oscillations in virus and IEs occurred at intermediate
transfer volumes, as shown for 40 and 90 microliter
transfers. At transfer volumes of 100 microliters IE pro-
duction dominated, and low productivities and levels of
virus particles served to sustain the IE population.
Table 1 Model parameter values
Parameter Description Value 95% Units
Wild type virus burst size b 2670 ± 160 PFU/cell
IE burst size d 420 ± 10 IE/cell
Factor to describe an IEs as multiple particles z 190 ± 10 IU/IE
Extent of yield decrease of wild type virus with additional IUs present p 880 ± 20 PFU
cell
IU
cell
⋅ ⎛
⎝
⎜
⎞
⎠
⎟ log
Extent of yield increase of wild type virus at very high interference q 0.47 ± 0.10 PFU/IU
Cut-off between high and very high interference w 290 ± 150 IU/cell
Extent of yield increase of IE with additional IUs present r 30 ± 5 IE
cell
IU
cell
⋅ ⎛
⎝
⎜
⎞
⎠
⎟ log
Extent of yield decrease of IE with additional IUs present above w s 80 ± 5 IE
cell
IU
cell
⋅ ⎛
⎝
⎜
⎞
⎠
⎟ log
IE generation rate g 0.001 ± 0.0002 IE/cell
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Page 5 of 10The interactions between virus and IE levels across
passages may be summarized by plotting the IE produc-
tivity versus virus productivity at each passage, showing
both steady-state (Fig. 4c) and oscillatory (Fig. 4d) beha-
viors. Trajectories start from the x-axis where the initial
virus levels are high and IE levels are low. From passage
1 to passage 2 the IE yield increases with little reduction
in the virus productivity. For relatively low transfer
volumes of 20 microliters the trajectory coils counter-
clockwise as it approaches the steady-state (Fig. 4c). The
coil shape is indicative of damped oscillations in both
the virus and IE yield during passaging. For larger trans-
fer volumes, cultures span greater ranges in productiv-
ities, as shown for a transfer volume of 40 microliters
(Fig. 4d), where trajectories stably oscillate without dam-
pening to a steady state. As the transfer volume
increases from 40 to 90 microliters the amplitude of the
oscillations decreases (Fig. 4a). As transfer volumes
increase still further amplitudes of oscillation (and mag-
nitude of trajectory loops) decrease until the oscillations
cease at transfer volumes of at least 100 microliters, as
shown in Fig. 4a/4c. Under such conditions, the trajec-
tory reaches a maximum IE productivity at passage 2,
both yield of virus and IE drops by passage 3, and the
virus yield continues to drop until the steady state is
reached.
The impact of host-cell availability for infection was
tested by simulating passages using either fixed or fluc-
tuating cell numbers. Fluctuating conditions were simu-
lated by using cell numbers that were experimentally
measured during the fixed-volume passage, at the time
of infection (Fig. 1a). Both virus and IE productivity
exhibited 10-100 fold changes in passage-to-passage
levels, as shown in Fig. 4e and Fig. 4f, respectively. The
most distinguishing feature was a major drop in
productivity of wild-type virus and IEs in passages 9 and
10, respectively. Passage 9 had a relatively low cell count
at 0.83 × 10
6 per well, where the mean across all pas-
sages was (1.8 ± 0.6) × 10
6 cells per well, respectively.
The model was used to simulate the effects of differ-
ent initial IE levels on the behavior of virus and IE levels
across fixed-volume passages, as shown in Fig. 4g and
Fig. 4h, respectively. Initial levels from zero to 10
4 IE
per ml had no effect on the productivity of virus or IE
at steady state. However, transients in virus and IE pro-
ductivity differed in duration, requiring up to 9 passages
to achieve steady-state levels.
Curing of infection
Finally, we used the model to explore conditions for
spontaneous curing of infection, where the production
of virus can be driven to zero. Fig. 4i shows an example
of a spontaneously cured infection. For the infection to
spontaneously cure, the model requires that co-infec-
tions produce no virus. This condition was implemented
in the model by setting q = 0, rather than q =0 . 4 7
(Table 1).
Discussion
By maintaining a fixed multiplicity of infection (MOI)
across serial virus passages we observed a regular pat-
tern of population behavior: average yields of virus
declined more rapidly for passages performed at higher
MOIs (Fig. 1b). The earlier and faster decline in virus
level at higher MOI’s could be attributed most simply to
smaller dilution effects. Ath i g h e rM O Im o r ev i r u sa n d
more DI particles are transferred from one generation
to the next, enabling more rapid accumulation of DI
particles and greater inhibitory effects on virus growth.
Alternatively, high MOI infections in the absence of DI
Figure 3 Comparison of experimental data with models. (a) Fixed-MOI passages, with data (filled symbols, solid lines) and model (open
symbols, dashed lines) and (b) fixed-volume passages. The data are from Fig. 1, and predictions from the model incorporate experimentally
measured cell levels at each passage. The initial virus concentration (passage 1) for models is based on the measured stock virus titer, where we
assume the stock virus was free of any DI particles or IE activity. Models all used parameters from Table 1.
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Page 6 of 10Figure 4 Sensitivity of model predictions to different inputs. Effects of passage volume on (a) production of virus, and (b) production of
interference equivalents (IE). Trajectory plots for (c) virus and IE production for 20- and 150-microliter passages, and (d) virus and IE production
for 40-microliter passages. Predicted effects of cell level on (e) virus production and (f) IE production using the experimentally observed cell
levels (solid lines), and constant cell number of 2 × 10
6 cell/passage (dashed lines). Effect of initial IE concentration on (g) virus production and
(h) IE production. (i) Conditions for curing of infection for virus (filled circles) and IE (open circles); here the value of parameter q was set to zero
and the simulation was implemented for fixed-volume passages with 50 microliters. Simulation input values for passage 1 were 1 × 10
9 PFU/ml,
400 IE/ml, 2 × 10
6 cell/passage, and 2-microliter passaged volumes from total culture well (2 ml), unless otherwise noted.
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Page 7 of 10particles could be associated with intrinsically higher
rates of de novo DI particle production. To test this pos-
sibility we allowed for de novo DI particle generation in
our model and found that declines in virus yields for
passages at MOI 100 and MOI 10 could be reasonably
accounted for by assuming a fixed intrinsic rate of
de novo DI particle generation (g = 0.01 IE/cell), as
shown in Fig. 3a. In contrast, the model failed to cap-
ture the extent of observed yield reduction for passages
performed at MOI 5 and MOI 1. For these lower MOI
a better agreement between the model and the data
could be obtained by incorporating a significantly higher
rate of DI particle generation into the model (g = 20 IE/
cell, not shown). A higher DI particle generation rate
for conditions of lower MOI may initially seem paradox-
ical, because the generation of DI particles should
depend on the number of replication events, which
would be reduced at lower MOI. However, it should be
noted that the DI particle generation rates are expressed
as IE generated per infected cell. Other mechanisms
may also play a role in the mismatch between model
and data at low MOI. For example, DI particle popula-
tions may evolve to more potently inhibit amplification
of virus in cells co-infected with both virus and DI par-
ticles, or de novo generated DI particles may emerge
and displace existing DI particles [18,33,34]. Further stu-
dies on isolated DI particle sub-populations will be
needed to elucidate mechanisms responsible for the
differences between the model and data at low MOI.
What causes the chaotic population dynamics that is a
hallmark of fixed-volume serial virus cultures? Mathe-
matical models of passage behavior have previously sug-
gested how chaotic behavior can arise during fixed-
volume passages [21], but these models have been based
on assumptions that cells co-infected with standard and
DI particles produce only DI particles. They have also
assumed constant yields of DI particles are produced
from co-infected cells. These assumptions are not gener-
ally valid based on our recent experimental and model-
ing studies of VSV growth on BHK cells [28].
Specifically, co-infected cells produce both virus and DI
particles rather than only DI particles. Moreover, aver-
age yields of virus and DI particles determined from co-
infected cells were not constant; instead, they depended
on DI particle dose. These experimental results were
used here to develop new mathematical models and
simulate the behavior of virus and DI particle popula-
tions in fixed-volume passages. The simulated popula-
tions exhibited no chaotic behavior. Instead, initial
transients spanning up to six passages settled into either
steady-state or regular oscillatory behaviors (Fig. 4a-d).
Experimental measures of standard and DI particle
behavior over fixed-volume VSV passages have shown
cyclic behavior [32], but the observed six passages were
too few to establish whether regular oscillations were
feasible. We carried out fixed-volume passages in the
laboratory and observed irregular changes in the virus
productivity from one passage to the next, most notably
between passages 6 and 10 (Fig. 1a). When we expanded
the model to incorporate experimentally measured host-
cell levels at each passage then the predicted virus levels
exhibited significant fluctuations, especially beyond pas-
sage 6, with a greater than 100-fold drop between pas-
sages 8 and 9, as observed in experiments (Fig. 3b and
Fig. 4e/4f). Relatively small changes in cell levels can
give rise to large changes in virus production from
infected and co-infected cells, owing to the non-linear
relationship between virus production(VN+1) and cell
level(CN) shown in Eq. 1. A testable prediction of the
model is that by controlling experiments to reduce fluc-
tuations in cell levels one should observe more regular
behavior of virus levels (e.g., steady-state or regular
oscillations) during constant-volume passages, as
reflected in Fig. 4a-d. More broadly, these results show
that passage-to-passage changes in the virus level can
arise from competition between virus and DI particles
for host-cell resources, as well as from fluctuations in
the level of host cells. From an ecological perspective,
fluctuations in host cells may be viewed as periodic
mortality events that can significantly impact the preda-
tor-prey dynamics [35].
To run our model one must provide an initial condi-
tion that specifies not only the concentration of virus
particles, but also the concentration of DI particles in
the initial passage. In the laboratory, the concentration
of DI particles in the initial passage will depend on the
history of the stock solution. For example, if the stock is
amplified from an isolated plaque at low MOI or serially
passaged at high MOI it may contain negligible or high
levels of DI particles, respectively. In our model this
input was found to have no effect on the steady-state
dynamics of the virus and DI particle populations (Fig.
4g/4h). Even in the absence of initial DI particles the de
novo generation of DI particles produced interference
activity that was rapidly amplified in co-infections with
wild-type virus. It appears that once DI particles are
a v a i l a b l et h e yw i l lt e n dt od o m i n a t es u b s e q u e n tc o -
infections. While new or different DI particles could, in
principle, be generated by de novo processes, the low
productivity of such processes prevents de novo DI par-
ticles from being competitive with existing DI particles.
This dominance of initial DI particles has been found
experimentally by observing how parallel cultures
initiated from a common stock preserve DI particles
present in the stock [36].
Some cells can make nearly a million-fold more DI
particles than other cells, depending on how they are
infected. When a cell is infected with viable virus, in the
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Page 8 of 10absence of any DI particles, few if any DI particles will
be made, reflecting the small de novo rate of DI particle
generation. This rate was estimated for VSV at 0.001 IE/
cell. However, when a cell is co-infected with viable
virus and DI particles, then many DI particles can be
made, reflecting their ability to divert resources from
virus to DI particle production.
Experiments suggest that more than 500 IE per cell
can be produced under optimal conditions for DI parti-
c l ep r o d u c t i o n[ 2 8 ] .I fw ea s s u m eas i n g l eD Ip a r t i c l e
corresponds to a single interference unit (IU), then we
may estimate that optimal condition for DI particle pro-
duction make (500 IE/cell × 200 IU/IE × 1 DI particle/
IU) or 100,000 DI particles per cell. At the other end of
the spectrum, the least productive or de novo rate of DI
particle generation is (0.001 IE/cell × 200 IU/IE × 1 DI
particle/IU) or 1 DI particle from every five infected
cells. Thus, a 500,000-fold difference in DI particle
yields separates the most productive from the least pro-
ductive cells. A more expanded view of productivity,
which includes the production of both DI and viable
particles, may be concisely expressed in terms of a parti-
cle-to-PFU ratio. Such a ratio can be experimentally
determined by estimating the number of virus-sized par-
ticles in a sample by electron microscopy and dividing
by the number of viable virus particles measured by the
plaque assay. If we assume that only DI and viable parti-
cles are produced by a co-infected cell, then we estimate
a particle-to-PFU ratio of 38 (or 102,670 particles/2670
PFU) based on maximal production of DI and viable
particles. This estimate is consistent with the observed
range for VSV from 10 to 50 particle-to-PFU [37].
Although spontaneous curing of virus infections by DI
particles has not been experimentally observed, the pos-
s i b i l i t yh a sb e e ne x p l o r e di np r e v i o u sm o d e l s[ 2 1 , 2 2 ] .
Our data-driven model indicates VSV infections cannot
be spontaneously cured because infected cells produce
viable virus under all conditions, even when DI particles
most potently interfere with virus production. If desired,
our model could be adapted to simulate a curing effect
by setting the parameter q to zero, so cells co-infected
with virus and a high level of DI particles would pro-
duce only DI particles. Others have found that indivi-
dual cells isolated from a co-infected cell population
produced no detectable virus, suggesting a curing effect,
but other cells drawn from the same population did
produce virus [38]. The absence of experimental support
to date for spontaneous curing of infections by DI parti-
cles should not detract from advancing their applica-
tions. DI particles have potentially therapeutic
applications as enabling tools for vaccination [39,40], as
prophylactics, or as therapeutics [41]. In an infected
patient, we expect that virus and DI particles would
grow and spread continuously on susceptible host cells,
so our current model would have limited application
owing to its focus on discrete population passages. Our
data-driven modeling approach could, however, be
extended to develop a continuous rather than discrete
model. We envision that such a data-driven continuous
model would be based on experiments of growth
kinetics that explicitly accounted for the dynamic inter-
actions between cells, virus and DI particles.
We are seeking to develop experimental measures and
theoretical methods to better understand how viruses
grow and how their infections spread. Our main contri-
bution here has been to better link quantitative experi-
ments of virus and DI particle populations with
quantitative models. This approach will be enhanced in
the future by incorporating additional measures, beyond
plaque counting, including electron microscopy (particle
counting), quantitative PCR, and next-generation
sequencing. Ultimately, our approach aims to provide a
predictive capability that will enable the long-term con-
trol of virus infections.
Conclusions
Serial-passage cultures of virus at fixed multiplicity of
infection (MOI) produced regular patterns of attenuated
virus production across passages. These patterns of stee-
per declines in virus production at higher MOI could be
accounted for by a mathematical model that incorpo-
rated interactions among virus particles, defective inter-
fering (DI) particles, and cells to predict yields of virus
and DI particle production from co-infected cells.
Further, analysis of fluctuating virus populations pro-
vided evidence for a high sensitivity of virus and DI par-
ticle population dynamics to small changes in the levels
of cellular resources.
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